Cancer chemotherapy reduces plasma total antioxidant capacity in children with malignancies

Leukemia Research

Volumn 29, Issue 1, 2005, Pages 11-16

  Papageorgiou, Maria ^a   Stiakaki, Eftichia ^a   Dimitriou, Helen ^a   Malliaraki, Niki ^a   Notas, George ^a   Castanas, Elias ^a   Kalmanti, Maria ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

acute lymphoblastic leukemia; acute myeloid leukemia; ALL; AML; Antioxidant capacity; central nervous system; CNS; corrected total antioxidant capacity; cTAC; PMNs; polymorphonuclears; reactive oxygen species; ROS; TAC; total antioxidant capacity

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASPARAGINASE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; REACTIVE OXYGEN METABOLITE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; INFANT; MALE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; MALE; NEOPLASMS; PROSPECTIVE STUDIES; REACTIVE OXYGEN SPECIES;

EID: 8444223109     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.04.017     Document Type: Article

References (31)

1. Kerr M.E., Bender C.M., Monti E.J. An introduction to oxygen free radicals. Heart Lung. 25:1996;200-209
2. Young I.S., Woodside J.V. Antioxidants in health and disease. J Clin Pathol. 54:2001;176-186
3. Kampa M., Nistikaki A., Tsaousis V., Maliaraki N., Notas G., Castanas E.A. New automated method for the determination of the total antioxidant capacity (TAC) of human plasma, based on the crocin bleaching assay. BMC Clin Pathol. 2:2002;3
4. Prior R.L., Cao G. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med. 27:1999;1173-1181
5. Barbaste M., Berke B., Dumas M., Soulet S., Delaunay J.C., Castagnino C., et al. Dietary antioxidants, peroxidation and cardiovascular risks. J Nutr Health Aging. 6:2002;209-223
6. Senturker S., Karahalil B., Inal M., Yilmaz H., Muslumanoglu H., Gedikoglu G., et al. Oxidative DNA base damage and antioxidant enzyme levels in childhood acute lymphoblastic leukemia. FEBS Lett. 416:1997;286-290
7. Malvy D.J., Arnaud J., Burtschy B., Sommelet D., Leverger G., Dostalova L., et al. Antioxidant micronutrients and childhood malignancy during oncological treatment. Med Pediatr Oncol. 29:1997;213-217
8. Rothe G., Valet G. Flow cytometric assays of oxidative burst activity in phagocytes. Methods Enzymol. 233:1994;539-548
9. Conklin K.A. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer. 37:2000;1-18
10. Carew J.S., Zhou Y., Albitar M., Carew J.D., Keating M.J., Huang P. Mitochondrial DNA mutations in primary leukemia cells afterchemotherapy: clinical significance and therapeutic implications. Leukemia. 17:2003;1437-1447
11. Pelicano H., Feng L., Zhou Y., Carew J.S., Hileman E.O., Plunkett W., et al. Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem. 26:2003;37832-37839
12. Malliaraki N., Mpliamplias D., Kampa M., Perakis K., Margioris A.N., Castanas E. Total and corrected antioxidant capacity in hemodialyzed patients. BMC Nephrol. 4:2003;4-11
13. Sangeetha P., Das U.N., Koratkar R., Suryaprabha P. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med. 8:1990;15-19
14. Jeanne A., Drisko J.A., Chapman J., Hunter V.J. The use of antioxidant therapies during chemotherapy. Gynecol Oncol. 88:2003;434-439
15. Schmitt C.A., Lowe S.W. Apoptosis and therapy. J Pathol. 187:1999;127-137
16. Prasad K.N., Hernandez C., Edwards-Prasad J., Nelson J., Borus T., Robinson W.A. Modification of the effect of tamoxifen, cisplatin, DTIC and interferon-2b on human melanoma cells in culture by a mixture of vitamins. Nutr Cancer. 22:1994;233-245
17. Weijl N.I., Cleton F.J., Osanto S. Free radicals and antioxidants in chemotherapy induced toxicity. Cancer Treat Rev. 23:1997;209-240
18. Agus D.B., Vera J.C., Golde D.W. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res. 59:1999;4555-4558
19. Labriola D., Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology. 13:1999;1003-1012
20. Salganik R.I., Albright C.D., Kim J., Zeisel S.H., Sivashinskiy M.S., Van Dyke T.A. Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis. 21:2000;909-914
21. McCall M.R., Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med. 26:1999;1034-1053
22. Prasad K.N., Kumar A., Kochupillai V., Cole W.C. High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. Gynecologic Oncology. 88:2003;434-439
23. Cameron E., Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci. 73:1976;3685-3689
24. Lamson D.W., Brignall M.S. Antioxidants in cancer therapy: their actions and interactions with oncologic therapies. Altern Med Rev. 4:1999;304-329
25. Lupulescu A. Ultrastructure and cell surface studies of cancer cells following vitamin C administration. Exp Toxicol Pathol. 4:1992;3-9
26. Riordan N.H., Riordan H.D., Meng Y.L., Jackson J.A. Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med Hypotheses. 44:1995;207-213
27. Park C.H., Amare M., Savin M.A., Hoogstraten B. Growth suppression of human leukemic cells in vitro by L-ascorbic acid. Cancer Res. 40:1980;1062-1065
28. Koch C.J., Biaglow J.E. Toxicity, radiation sensitivity modification, and metabolic effects of dehydroascorbate and ascorbate in mammalian cells. J Cell Physiol. 94:1978;299-306
29. Park C.H., Kimler B.F. Growth modulation of human leukemic, preleukic, and myeloma progenitor cells by L-ascorbic acid. Am J Clin Nutr. 54:1991;1241S-1246S
30. Prasad K.N., Cole W., Hoveland P. Cancer prevention studies: past, present, and future. Nutrition. 14:1998;197-210
31. Chinery R., Brockman J.A., Peeler M.O., Shyr Y., Beauchamp R.D., Coffey R.J. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBP. Nat Med. 3:1997;1233-1241